Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-01

Clinical Trial Update: Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy [NA]

View source ↗

Summary

A completed clinical trial evaluating allogenic umbilical cord blood combined with erythropoietin for cerebral palsy has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • allogenic umbilical cord blood and erythropoietin combination therapy

Snippet

Sponsor: Sung Kwang Medical Foundation | Conditions: Cerebral Palsy | NA | Status: COMPLETED | Results posted: 2012-03-01